Sage Therapeutics

Sage Therapeutics, major depressive disorder, Zurzuvae, Layoff

Sage slashes 40% of staff, reshuffles leadership after zuranolone setback

Anika Sharma

Sage Therapeutics is set to undergo a significant transformation by reducing its workforce by 40% following a setback in gaining ...

Zurzuvae: FDA’s First Oral Drug for Postpartum Depression

FDA Approves Zurzuvae: A Game-Changer for Postpartum

SG Tylor

Source – Biogen Biogen and Sage Therapeutics have received FDA approval for Zurzuvae (zuranolone) 50 mg, a breakthrough treatment for ...